Adherence to antiretroviral medications in an inner-city population

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 5, 1999, Pages 498-502

  Weidle, Paul J ^a,b   Ganea, Camelia E ^c   Irwin, Kathleen L ^a   McGowan, Joseph P ^c   Ernst, Jerome A ^c   Olivo, Noemi ^c   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Adherence; Antiretroviral Therapy; HIV; Medications

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; URBAN POPULATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0033572606     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199912150-00011     Document Type: Article

References (15)

1. Adherence to new HIV therapies: a research conference [conference report]. Washington, DC, November 1997.
2. Samuels JE, Hendrix J, Hilton M, Marantz PR, Sloan V, Butkus Small C. Zidovudine therapy in an inner city population. J Acquir Immune Defic Syndr 1990;3:877-83.
3. Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med 1992;92:495-502.
4. Broers B, Morabia A, Hirschel B. A cohort study of drug users compliance with zidovudine treatment. Arch Intern Med 1994;154: 1121-7.
5. Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care 1995;7: 439-47.
6. Singh N, Squier C, Sivek C, Wagener M, Hong Nguyen M, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-9.
7. Gallant JE, Block DS. Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients. J Int Assoc Physicians AIDS Care 1998;4:32-5.
8. Lopez-Suarez A, Fernandez-Gutierrez del Alamo C, Perez-Guzman E, Giron-Gonzalez JA. Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS 1998;12: 685-6.
9. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:117-25.
10. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA 1993;269: 2779-81.
11. O'Brien MK, Petrie K, Raeburn J. Adherence to medication regimens: updating a complex medical issue. Med Care Rev 1992:49:435-4.
12. Wright EC. Non-compliance or how many aunts has Matilda? Lancet 1993;342:909-13.
13. Knobel H, Carmona A, Grau S, Pedro-Botet J, Dies A. Adherence and effectiveness of highly active antiretroviral therapy. Arch Intern Med 1998;158:1953.
14. Graham KK, Beeler LH, Sension MG, Renae S. Interventions and patient outcome from a pharmacist-based HIV medication adherence referral clinic [abstract 32323]. Presented at the XII World AIDS Conference, Geneva, Switzerland, 1998.
15. Weidle, PJ, Ganea CE, Irwin KL, et. al. Presence of HIV-1 group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States [abstract 13225]. Presented at the XII World AIDS Conference, Geneva, Switzerland, 1998.